Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Transpara by ScreenPoint Medical has been validated in over 35 peer-reviewed publications, shown to improve early detection of breast cancer with high sensitivity and specificity. It has analyzed over five million mammograms worldwide and demonstrated consistent results across patient demographics. The system provides a risk score to help triage cases efficiently. Clinical research shows that low-risk scores have a negative predictive value of up to 99.97%. The product fits seamlessly into radiology workflows and supports both FFDM (Full Field Digital Mammography) and DBT (Digital Breast Tomosynthesis). Used in prospective clinical trials internationally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ScreenPoint Medical.